Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.
about
Overview and recent advances in the treatment of neuroblastoma.KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With NeuroblastomaIncidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015.Advances in emerging drugs for the treatment of neuroblastoma.Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database.
P2860
Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tandem high-dose chemotherapy ...... h-risk neuroblastoma patients.
@en
type
label
Tandem high-dose chemotherapy ...... h-risk neuroblastoma patients.
@en
prefLabel
Tandem high-dose chemotherapy ...... h-risk neuroblastoma patients.
@en
P2093
P2860
P356
P1476
Tandem high-dose chemotherapy ...... h-risk neuroblastoma patients.
@en
P2093
C Pasqualini
D Valteau-Couanet
M-A Raquin
V Lapierre
P2860
P2888
P304
P356
10.1038/BMT.2015.264
P407
P577
2015-11-02T00:00:00Z
P6179
1020032764